Navidea Biopharmaceuticals (NAVB) SC 13D/A Navidea Biopharmaceuticals, Inc.

EXHIBIT 99.2

TRANSACTIONS SINCE MARCH 3, 2016

The following Reporting Persons engaged in the following transactions with respect to the Issuer’s Common Stock since March 3, 2016:

Platinum Partners Value Arbitrage Fund L.P.

Transaction Date	Number of Shares		Price per Share		Type of Transaction
2/24/2016		11,693	$	0.96	Purchase
3/3/2016		1,548	$	0.9651	Purchase
3/22/2016		2,337	$	0.95	Purchase
3/23/2016		53,893	$	0.95	Purchase
3/24/2016		38,539	$	0.958	Purchase
3/28/2016		91,778	$	0.94	Purchase
3/28/2016		180,000	$	0.95	Purchase
3/30/2016		63,565	$	0.9281	Purchase
3/31/2016		20,500	$	0.93	Purchase
3/31/2016		3,147,290	$	1.95	Purchase
4/4/2016		3,400	$	1.0221	Purchase

There were no other transactions effected by any other Reporting Person since March 3, 2016.